Isoform Specific Histone Deacetylase Inhibitor Treatment in a Swine Model of Polytrauma and Sepsis
异构体特异性组蛋白脱乙酰酶抑制剂治疗多发伤和脓毒症猪模型
基本信息
- 批准号:9794007
- 负责人:
- 金额:$ 6.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAdverse effectsAdverse reactionsAffectAftercareAmericanAmericasAnimal ModelBrainCause of DeathCell Culture TechniquesCell DeathCell LineCell SurvivalCessation of lifeClinicalCognitiveColonCrush InjuryDataDoseEffectivenessFDA approvedFamily suidaeFunctional disorderGenesGenomicsGrantHemorrhageHemorrhagic ShockHistologyHistone DeacetylaseHistone Deacetylase InhibitorInjuryIntra-abdominalLacerationLesionLiverMagnetic Resonance ImagingMeasuresMilitary PersonnelModelingNeurological outcomeOutcomePathway interactionsPatientsPhenotypePhysiologicalProtein IsoformsProteinsProteomicsResuscitationRib FracturesRodent ModelSepsisSeptic ShockShockTestingTherapeutic EffectTissuesToxic effectTraumaTraumatic Brain InjuryTraumatic injuryUnited States National Institutes of HealthWorkblood productcognitive functioncognitive testingimprovedinhibitor/antagonistmortalitynovelnovel therapeuticspreventsoft tissuetargeted treatment
项目摘要
PROJECT SUMMARY/ABSTRACT
Traumatic injuries are the leading cause of death in young Americans. In civilian and military
trauma, hemorrhage and traumatic brain injuries (TBI) account for the majority of these deaths.
Current treatment is focused on hemorrhage control, blood product resuscitation and support of
physiologic parameters. No therapy exists to specifically prevent cellular dysfunction that occurs
with shock or traumatic injuries. We have shown that in clinically realistic models of trauma,
hemorrhagic shock and TBI, treatment with nonselective histone deacetylase (HDAC) inhibitors
improves survival and cognitive function. However, the doses needed for this effect have been
very high, raising concern for toxicity. There are 18 known isoforms of HDAC, and we believe
that being able to develop a more targeted therapy to inhibit specific isoforms of HDAC would
achieve the desired therapeutic effect while decreasing concern for toxicity and adverse
reactions. This proposal is a continuation of work done on NIH grant R01GM84127. As part of
this grant, we have tested various isoform specific HDAC inhibitors in cell line and rodent
models of hemorrhage, trauma and septic shock. Work from cell culture data and small animal
models will be used to select the appropriate isoform specific HDAC inhibitors to test in a
clinically realistic swine model of hemorrhagic shock, polytrauma including TBI and intra-
abdominal sepsis. Using this model, we will be able to compare long term survival and cognitive
outcomes after treatment with conventional resuscitation, nonselective HDAC inhibitor and
isoform specific HDAC inhibition. Additionally, tissue from swine will be used to elucidate
underlying mechanisms that contribute to cell death and dysfunction during trauma, and how
HDAC inhibition promotes a “pro-survival” phenotype at the genomic and proteomic level.
项目概要/摘要
外伤是美国年轻平民和军人死亡的主要原因。
外伤、出血和创伤性脑损伤(TBI)占这些死亡的大部分。
目前的治疗重点是控制出血、血液制品复苏和支持
不存在专门预防细胞功能障碍发生的治疗方法。
我们已经证明,在临床真实的创伤模型中,
失血性休克和 TBI,使用非选择性组蛋白脱乙酰酶 (HDAC) 抑制剂治疗
提高生存率和认知功能。然而,这种效果所需的剂量是有限的。
非常高,引起人们对毒性的担忧。我们相信 HDAC 有 18 种已知亚型。
能够开发出更有针对性的疗法来抑制 HDAC 的特定亚型将
达到预期的治疗效果,同时减少对毒性和不良反应的担忧
该提案是 NIH 拨款 R01GM84127 工作的延续。
这笔资助,我们在细胞系和啮齿动物中测试了各种异构体特异性 HDAC 抑制剂
根据细胞培养数据和小动物建立出血、创伤和感染性休克模型。
模型将用于选择合适的异构体特异性 HDAC 抑制剂来进行测试
失血性休克、多发伤(包括 TBI 和体内损伤)的临床真实猪模型
使用该模型,我们将能够比较长期生存率和认知能力。
常规复苏、非选择性 HDAC 抑制剂和治疗后的结果
此外,猪的组织将用于阐明异构体特异性 HDAC 抑制。
创伤期间导致细胞死亡和功能障碍的潜在机制,以及如何
HDAC 抑制可在基因组和蛋白质组水平上促进“促生存”表型。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Validation of intraosseous delivery of valproic acid in a swine model of polytrauma.
- DOI:10.1136/tsaco-2021-000683
- 发表时间:2021
- 期刊:
- 影响因子:2
- 作者:Biesterveld BE;O'Connell R;Kemp MT;Wakam GK;Williams AM;Pai MP;Alam HB
- 通讯作者:Alam HB
Valproic acid improves survival and decreases resuscitation requirements in a swine model of prolonged damage control resuscitation.
在长期损害控制复苏的猪模型中,丙戊酸可提高存活率并降低复苏要求。
- DOI:10.1097/ta.0000000000002281
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Williams,AaronM;Bhatti,UmarF;Biesterveld,BenE;Graham,NathanJ;Chtraklin,Kiril;Zhou,Jing;Dennahy,IsabelS;Kathawate,RanganathG;Vercruysse,ClaireA;Russo,RachelM;Li,Yongqing;Alam,HasanB
- 通讯作者:Alam,HasanB
Valproic Acid Protects Against Acute Kidney Injury in Hemorrhage and Trauma.
- DOI:10.1016/j.jss.2021.04.014
- 发表时间:2021-10
- 期刊:
- 影响因子:0
- 作者:Biesterveld BE;Siddiqui AZ;O'Connell RL;Remmer H;Williams AM;Shamshad A;Smith WM;Kemp MT;Wakam GK;Alam HB
- 通讯作者:Alam HB
Valproic acid treatment rescues injured tissues after traumatic brain injury.
- DOI:10.1097/ta.0000000000002918
- 发表时间:2020-12
- 期刊:
- 影响因子:0
- 作者:Biesterveld BE;Pumiglia L;Iancu A;Shamshad AA;Remmer HA;Siddiqui AZ;O'Connell RL;Wakam GK;Kemp MT;Williams AM;Pai MP;Alam HB
- 通讯作者:Alam HB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ben Edwin Biesterveld其他文献
Ben Edwin Biesterveld的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis
HIV 相关结核病治疗毒性、失败和复发的预测因素
- 批准号:
9199006 - 财政年份:2016
- 资助金额:
$ 6.1万 - 项目类别:
Altered transport and epigenomic changes in maneb-potentiated neurotoxicity
代森锰增强神经毒性的转运和表观基因组变化
- 批准号:
8913968 - 财政年份:2013
- 资助金额:
$ 6.1万 - 项目类别:
Altered transport and epigenomic changes in maneb-potentiated neurotoxicity
代森锰增强神经毒性的转运和表观基因组变化
- 批准号:
8716885 - 财政年份:2013
- 资助金额:
$ 6.1万 - 项目类别:
Altered transport and epigenomic changes in maneb-potentiated neurotoxicity
代森锰增强神经毒性的转运和表观基因组变化
- 批准号:
8735149 - 财政年份:2013
- 资助金额:
$ 6.1万 - 项目类别:
Altered transport and epigenomic changes in maneb-potentiated neurotoxicity
代森锰增强神经毒性的转运和表观基因组变化
- 批准号:
8425616 - 财政年份:2012
- 资助金额:
$ 6.1万 - 项目类别: